The oncology devices market size has grown rapidly in recent years. It will grow from $177.72 billion in 2025 to $210.15 billion in 2026 at a compound annual growth rate (CAGR) of 18.2%. The growth in the historic period can be attributed to increasing global cancer incidence rates, expansion of hospital oncology departments, growing demand for early diagnosis technologies, availability of advanced imaging systems, rising awareness of cancer screening programs.
The oncology devices market size is expected to see rapid growth in the next few years. It will grow to $397.27 billion in 2030 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to increasing adoption of personalized cancer treatment devices, rising investments in oncology infrastructure, expansion of outpatient cancer treatment facilities, growing use of AI-driven diagnostic tools, increasing focus on precision oncology solutions. Major trends in the forecast period include increasing adoption of advanced cancer diagnostic devices, rising use of image-guided oncology therapies, growing integration of minimally invasive cancer treatment tools, expansion of precision radiation therapy equipment, enhanced focus on early cancer detection.
The growing demand for chemotherapy is anticipated to drive the expansion of the oncology devices market in the coming years. Chemotherapy is a cancer treatment that involves the use of potent drugs to eliminate rapidly dividing cells, thereby slowing or halting tumor growth and spread. The rising demand for chemotherapy is driven by the increasing global incidence of cancer, as a higher number of diagnosed cases leads to greater need for effective and widely available treatments capable of addressing various cancer types and stages. Oncology devices support chemotherapy by facilitating safer and more accurate drug delivery and monitoring, which improves treatment efficacy and patient outcomes. For example, in January 2025, according to the U.S. National Cancer Institute, a U.S.-based federal cancer research agency, new cancer cases in the United States are projected to reach 2.04 million, up from 1.96 million in 2023, underscoring the growing need for chemotherapy administration systems. Therefore, the rising demand for chemotherapy is contributing to the growth of the oncology devices market.
Major companies operating in the oncology devices market are concentrating on the development of advanced, precision-oriented solutions to enhance treatment accuracy, patient safety, and clinical workflow efficiency. These innovations focus on minimally invasive technologies, improved visualization, and real-time therapy optimization to support better outcomes across a wide range of cancer types. For example, in April 2025, ZEISS, a Germany-based medical technology company, obtained FDA 510(k) clearance for its INTRABEAM 700 system, a next-generation robotic-assisted intraoperative radiotherapy (IORT) platform intended for targeted radiation delivery in neuro-oncology and breast cancer procedures. The system provides increased precision, optimized ergonomics, and improved integration into surgical workflows, allowing clinicians to deliver localized radiation during surgery while reducing exposure to surrounding healthy tissue. By integrating advanced imaging, robotics, and treatment-planning capabilities, the INTRABEAM 700 improves therapeutic accuracy, enables faster clinical decision-making, and supports the industry’s transition toward technologically sophisticated, patient-focused oncology care.
In March 2024, Halma PLC, a UK-based company specializing in life-saving technologies that prevent injuries, save lives, and protect people and assets, acquired Rovers Medical Devices B.V. for $93.5 million. This acquisition is intended to expand Halma PLC's market presence in women's health and enhance its capabilities in cancer diagnostics. Rovers Medical Devices B.V. is a Netherlands-based company focused on designing, developing, and manufacturing medical devices for cancer screening.
Major companies operating in the oncology devices market are Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic plc, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., Navidea Biopharmaceuticals Inc.
North America was the largest region in the oncology devices market in 2025. Asia-Pacific was the second-largest region in the oncology devices market report. The regions covered in the oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the oncology devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are influencing the oncology devices market by increasing costs of imported imaging systems, radiation therapy equipment, endoscopic devices, precision components, and electronic subsystems used in cancer diagnosis and treatment. Hospitals and cancer centers in North America and Europe are most affected due to reliance on imported high-end oncology equipment, while Asia-Pacific faces pricing pressure on equipment manufacturing and exports. These tariffs are increasing capital investment requirements and slowing technology upgrades. However, they are also encouraging domestic manufacturing, localized assembly of oncology systems, and innovation in cost-efficient cancer care technologies.
The oncology devices market research report is one of a series of new reports that provides oncology devices market statistics, including oncology devices industry global market size, regional shares, competitors with a oncology devices market share, detailed oncology devices market segments, market trends and opportunities, and any further data you may need to thrive in the oncology devices industry. This oncology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Oncology devices are specialized medical devices utilized for the diagnosis, management, and treatment of cancer.
The primary device categories within the field of oncology devices include brachytherapy devices and endoscopic devices. Endoscopic devices serve a critical role in the diagnosis, management, and treatment of cancer by allowing healthcare professionals to visually inspect the internal body cavities and organs for abnormalities. These devices find applications in various cancer therapies, including chemotherapy, hormone therapy, biotherapy/immunotherapy, and radiation therapy. They are employed by a range of end-users, including hospitals, cancer research institutes, and other medical facilities dedicated to cancer care and research.
The oncology devices market consists of sales of brachytherapy devices and endoscopic devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The oncology devices market size is expected to see rapid growth in the next few years. It will grow to $397.27 billion in 2030 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to increasing adoption of personalized cancer treatment devices, rising investments in oncology infrastructure, expansion of outpatient cancer treatment facilities, growing use of AI-driven diagnostic tools, increasing focus on precision oncology solutions. Major trends in the forecast period include increasing adoption of advanced cancer diagnostic devices, rising use of image-guided oncology therapies, growing integration of minimally invasive cancer treatment tools, expansion of precision radiation therapy equipment, enhanced focus on early cancer detection.
The growing demand for chemotherapy is anticipated to drive the expansion of the oncology devices market in the coming years. Chemotherapy is a cancer treatment that involves the use of potent drugs to eliminate rapidly dividing cells, thereby slowing or halting tumor growth and spread. The rising demand for chemotherapy is driven by the increasing global incidence of cancer, as a higher number of diagnosed cases leads to greater need for effective and widely available treatments capable of addressing various cancer types and stages. Oncology devices support chemotherapy by facilitating safer and more accurate drug delivery and monitoring, which improves treatment efficacy and patient outcomes. For example, in January 2025, according to the U.S. National Cancer Institute, a U.S.-based federal cancer research agency, new cancer cases in the United States are projected to reach 2.04 million, up from 1.96 million in 2023, underscoring the growing need for chemotherapy administration systems. Therefore, the rising demand for chemotherapy is contributing to the growth of the oncology devices market.
Major companies operating in the oncology devices market are concentrating on the development of advanced, precision-oriented solutions to enhance treatment accuracy, patient safety, and clinical workflow efficiency. These innovations focus on minimally invasive technologies, improved visualization, and real-time therapy optimization to support better outcomes across a wide range of cancer types. For example, in April 2025, ZEISS, a Germany-based medical technology company, obtained FDA 510(k) clearance for its INTRABEAM 700 system, a next-generation robotic-assisted intraoperative radiotherapy (IORT) platform intended for targeted radiation delivery in neuro-oncology and breast cancer procedures. The system provides increased precision, optimized ergonomics, and improved integration into surgical workflows, allowing clinicians to deliver localized radiation during surgery while reducing exposure to surrounding healthy tissue. By integrating advanced imaging, robotics, and treatment-planning capabilities, the INTRABEAM 700 improves therapeutic accuracy, enables faster clinical decision-making, and supports the industry’s transition toward technologically sophisticated, patient-focused oncology care.
In March 2024, Halma PLC, a UK-based company specializing in life-saving technologies that prevent injuries, save lives, and protect people and assets, acquired Rovers Medical Devices B.V. for $93.5 million. This acquisition is intended to expand Halma PLC's market presence in women's health and enhance its capabilities in cancer diagnostics. Rovers Medical Devices B.V. is a Netherlands-based company focused on designing, developing, and manufacturing medical devices for cancer screening.
Major companies operating in the oncology devices market are Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic plc, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., Navidea Biopharmaceuticals Inc.
North America was the largest region in the oncology devices market in 2025. Asia-Pacific was the second-largest region in the oncology devices market report. The regions covered in the oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the oncology devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are influencing the oncology devices market by increasing costs of imported imaging systems, radiation therapy equipment, endoscopic devices, precision components, and electronic subsystems used in cancer diagnosis and treatment. Hospitals and cancer centers in North America and Europe are most affected due to reliance on imported high-end oncology equipment, while Asia-Pacific faces pricing pressure on equipment manufacturing and exports. These tariffs are increasing capital investment requirements and slowing technology upgrades. However, they are also encouraging domestic manufacturing, localized assembly of oncology systems, and innovation in cost-efficient cancer care technologies.
The oncology devices market research report is one of a series of new reports that provides oncology devices market statistics, including oncology devices industry global market size, regional shares, competitors with a oncology devices market share, detailed oncology devices market segments, market trends and opportunities, and any further data you may need to thrive in the oncology devices industry. This oncology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Oncology devices are specialized medical devices utilized for the diagnosis, management, and treatment of cancer.
The primary device categories within the field of oncology devices include brachytherapy devices and endoscopic devices. Endoscopic devices serve a critical role in the diagnosis, management, and treatment of cancer by allowing healthcare professionals to visually inspect the internal body cavities and organs for abnormalities. These devices find applications in various cancer therapies, including chemotherapy, hormone therapy, biotherapy/immunotherapy, and radiation therapy. They are employed by a range of end-users, including hospitals, cancer research institutes, and other medical facilities dedicated to cancer care and research.
The oncology devices market consists of sales of brachytherapy devices and endoscopic devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Oncology Devices Market Characteristics
3. Oncology Devices Market Supply Chain Analysis
4. Global Oncology Devices Market Trends and Strategies
5. Oncology Devices Market Analysis of End Use Industries
7. Global Oncology Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Oncology Devices Total Addressable Market (TAM) Analysis for the Market
9. Oncology Devices Market Segmentation
10. Oncology Devices Market Regional and Country Analysis
11. Asia-Pacific Oncology Devices Market
12. China Oncology Devices Market
13. India Oncology Devices Market
14. Japan Oncology Devices Market
15. Australia Oncology Devices Market
16. Indonesia Oncology Devices Market
17. South Korea Oncology Devices Market
18. Bangladesh Oncology Devices Market
19. Thailand Oncology Devices Market
20. Vietnam Oncology Devices Market
21. Malaysia Oncology Devices Market
22. Singapore Oncology Devices Market
23. Philippines Oncology Devices Market
24. Hong Kong Oncology Devices Market
25. New Zealand Oncology Devices Market
26. Taiwan Oncology Devices Market
27. South East Asia Oncology Devices Market
28. Western Europe Oncology Devices Market
29. UK Oncology Devices Market
30. Germany Oncology Devices Market
31. France Oncology Devices Market
32. Italy Oncology Devices Market
33. Spain Oncology Devices Market
34. Austria Oncology Devices Market
35. Belgium Oncology Devices Market
36. Denmark Oncology Devices Market
37. Finland Oncology Devices Market
38. Ireland Oncology Devices Market
39. Netherlands Oncology Devices Market
40. Norway Oncology Devices Market
41. Portugal Oncology Devices Market
42. Sweden Oncology Devices Market
42. Switzerland Oncology Devices Market
43. Eastern Europe Oncology Devices Market
44. Russia Oncology Devices Market
45. Czech Republic Oncology Devices Market
46. Poland Oncology Devices Market
47. Romania Oncology Devices Market
48. Ukraine Oncology Devices Market
49. North America Oncology Devices Market
50. USA Oncology Devices Market
51. Canada Oncology Devices Market
52. Mexico Oncology Devices Market
53. South America Oncology Devices Market
54. Brazil Oncology Devices Market
55. Chile Oncology Devices Market
56. Argentina Oncology Devices Market
57. Colombia Oncology Devices Market
58. Peru Oncology Devices Market
59. Middle East Oncology Devices Market
60. Saudi Arabia Oncology Devices Market
61. Israel Oncology Devices Market
62. Iran Oncology Devices Market
63. Turkey Oncology Devices Market
64. United Arab Emirates Oncology Devices Market
65. Africa Oncology Devices Market
66. Egypt Oncology Devices Market
67. Nigeria Oncology Devices Market
68. South Africa Oncology Devices Market
70. Oncology Devices Market Competitive Landscape and Company Profiles
71. Oncology Devices Market Other Major and Innovative Companies
74. Oncology Devices Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Oncology Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses oncology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for oncology devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oncology devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Brachytherapy Devices; Endoscopic Devices2) By Therapy: Chemotherapy; Hormone Therapy; Biotherapy/Immunotherapy; Radition Therapy
3) By End User: Hospitals; Cancer Research Institutes; Other End Users
Subsegments:
1) By Brachytherapy Devices: Afterloaders (High-Dose Rate (HDR) And Low-Dose Rate (LDR)); Applicators; Seeds; Accessories2) By Endoscopic Devices: Endoscopes (Flexible, Rigid, Capsule); Endoscopic Ultrasound Systems; Endoscopic Accessories
Companies Mentioned: Eckert & Ziegler BEBIG GmbH; Oncura Inc.; GE Healthcare; Medtronic plc; Varian Medical Systems Inc.; Elekta AB; Theragenics Corporation; Accuray Incorporated; Roche Diagnostics; IBA Group; Biogenex Laboratories; Becton Dickinson and Company; Siemens Healthineers; Philips Healthcare; Hologic Inc.; IBA AG; ViewRay Inc.; Canon Medical Systems Corporation; Brainlab; PerkinElmer; RaySearch Laboratories; Mevion Medical Systems; Vision RT; IsoRay; RefleXion Medical; Alpha Tau Medical; Nanobiotix; Mirada Medical Ltd.; Navidea Biopharmaceuticals Inc.
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Oncology Devices market report include:- Eckert & Ziegler BEBIG GmbH
- Oncura Inc.
- GE Healthcare
- Medtronic plc
- Varian Medical Systems Inc.
- Elekta AB
- Theragenics Corporation
- Accuray Incorporated
- Roche Diagnostics
- IBA Group
- Biogenex Laboratories
- Becton Dickinson and Company
- Siemens Healthineers
- Philips Healthcare
- Hologic Inc.
- IBA AG
- ViewRay Inc.
- Canon Medical Systems Corporation
- Brainlab
- PerkinElmer
- RaySearch Laboratories
- Mevion Medical Systems
- Vision RT
- IsoRay
- RefleXion Medical
- Alpha Tau Medical
- Nanobiotix
- Mirada Medical Ltd.
- Navidea Biopharmaceuticals Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 210.15 Billion |
| Forecasted Market Value ( USD | $ 397.27 Billion |
| Compound Annual Growth Rate | 17.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
